These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 30381536)
41. Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk. Hohman TJ; Cooke-Bailey JN; Reitz C; Jun G; Naj A; Beecham GW; Liu Z; Carney RM; Vance JM; Cuccaro ML; Rajbhandary R; Vardarajan BN; Wang LS; Valladares O; Lin CF; Larson EB; Graff-Radford NR; Evans D; De Jager PL; Crane PK; Buxbaum JD; Murrell JR; Raj T; Ertekin-Taner N; Logue MW; Baldwin CT; Green RC; Barnes LL; Cantwell LB; Fallin MD; Go RC; Griffith P; Obisesan TO; Manly JJ; Lunetta KL; Kamboh MI; Lopez OL; Bennett DA; Hardy J; Hendrie HC; Hall KS; Goate AM; Lang R; Byrd GS; Kukull WA; Foroud TM; Farrer LA; Martin ER; Pericak-Vance MA; Schellenberg GD; Mayeux R; Haines JL; Thornton-Wells TA; Alzheimers Dement; 2016 Mar; 12(3):233-43. PubMed ID: 26092349 [TBL] [Abstract][Full Text] [Related]
42. Mutation analysis of the MS4A and TREM gene clusters in a case-control Alzheimer's disease data set. Ghani M; Sato C; Kakhki EG; Gibbs JR; Traynor B; St George-Hyslop P; Rogaeva E Neurobiol Aging; 2016 Jun; 42():217.e7-217.e13. PubMed ID: 27084067 [TBL] [Abstract][Full Text] [Related]
43. Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer's disease. De Roeck A; Van den Bossche T; van der Zee J; Verheijen J; De Coster W; Van Dongen J; Dillen L; Baradaran-Heravi Y; Heeman B; Sanchez-Valle R; Lladó A; Nacmias B; Sorbi S; Gelpi E; Grau-Rivera O; Gómez-Tortosa E; Pastor P; Ortega-Cubero S; Pastor MA; Graff C; Thonberg H; Benussi L; Ghidoni R; Binetti G; de Mendonça A; Martins M; Borroni B; Padovani A; Almeida MR; Santana I; Diehl-Schmid J; Alexopoulos P; Clarimon J; Lleó A; Fortea J; Tsolaki M; Koutroumani M; Matěj R; Rohan Z; De Deyn P; Engelborghs S; Cras P; Van Broeckhoven C; Sleegers K; Acta Neuropathol; 2017 Sep; 134(3):475-487. PubMed ID: 28447221 [TBL] [Abstract][Full Text] [Related]
44. TREM2 and the Progression of Alzheimer's Disease. Gao L; Jiang T; Yao X; Yu L; Yang X; Li Y Curr Neurovasc Res; 2017; 14(2):177-183. PubMed ID: 28393702 [TBL] [Abstract][Full Text] [Related]
45. Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease. Jones L; Harold D; Williams J Biochim Biophys Acta; 2010 Aug; 1801(8):754-61. PubMed ID: 20420935 [TBL] [Abstract][Full Text] [Related]
46. The Impact of Complement Genes on the Risk of Late-Onset Alzheimer's Disease. Carpanini SM; Harwood JC; Baker E; Torvell M; The Gerad Consortium ; Sims R; Williams J; Morgan BP Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33804666 [TBL] [Abstract][Full Text] [Related]
47. Molecular mechanisms of the genetic risk factors in pathogenesis of Alzheimer disease. Kanatsu K; Tomita T Front Biosci (Landmark Ed); 2017 Jan; 22(1):180-192. PubMed ID: 27814610 [TBL] [Abstract][Full Text] [Related]
49. Blood clusterin levels, rs9331888 polymorphism, and the risk of Alzheimer's disease. Xing YY; Yu JT; Cui WZ; Zhong XL; Wu ZC; Zhang Q; Tan L J Alzheimers Dis; 2012; 29(3):515-9. PubMed ID: 22258514 [TBL] [Abstract][Full Text] [Related]
50. Recent studies on cellular and molecular mechanisms in Alzheimer's disease: focus on epigenetic factors and histone deacetylase. Dubey H; Gulati K; Ray A Rev Neurosci; 2018 Mar; 29(3):241-260. PubMed ID: 29397389 [TBL] [Abstract][Full Text] [Related]
51. Manifestations of Alzheimer's disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90. Heath L; Earls JC; Magis AT; Kornilov SA; Lovejoy JC; Funk CC; Rappaport N; Logsdon BA; Mangravite LM; Kunkle BW; Martin ER; Naj AC; Ertekin-Taner N; Golde TE; Hood L; Price ND; Sci Rep; 2022 Apr; 12(1):6117. PubMed ID: 35413975 [TBL] [Abstract][Full Text] [Related]
52. Genetics of Alzheimer's disease: new evidences for an old hypothesis? Lambert JC; Amouyel P Curr Opin Genet Dev; 2011 Jun; 21(3):295-301. PubMed ID: 21371880 [TBL] [Abstract][Full Text] [Related]
53. Genetic determinants of disease progression in Alzheimer's disease. Wang X; Lopez OL; Sweet RA; Becker JT; DeKosky ST; Barmada MM; Demirci FY; Kamboh MI J Alzheimers Dis; 2015; 43(2):649-55. PubMed ID: 25114068 [TBL] [Abstract][Full Text] [Related]
54. Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment. Lacour A; Espinosa A; Louwersheimer E; Heilmann S; Hernández I; Wolfsgruber S; Fernández V; Wagner H; Rosende-Roca M; Mauleón A; Moreno-Grau S; Vargas L; Pijnenburg YA; Koene T; Rodríguez-Gómez O; Ortega G; Ruiz S; Holstege H; Sotolongo-Grau O; Kornhuber J; Peters O; Frölich L; Hüll M; Rüther E; Wiltfang J; Scherer M; Riedel-Heller S; Alegret M; Nöthen MM; Scheltens P; Wagner M; Tárraga L; Jessen F; Boada M; Maier W; van der Flier WM; Becker T; Ramirez A; Ruiz A Mol Psychiatry; 2017 Jan; 22(1):153-160. PubMed ID: 26976043 [TBL] [Abstract][Full Text] [Related]
55. Effect of CLU and PICALM polymorphisms on AD risk: A study from south India. Shankarappa BM; Kota LN; Purushottam M; Nagpal K; Mukherjee O; Viswanath B; Varghese M; Bharath S; Jain S Asian J Psychiatr; 2017 Jun; 27():7-11. PubMed ID: 28558900 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of CD33 as a genetic risk factor for Alzheimer's disease. Estus S; Shaw BC; Devanney N; Katsumata Y; Press EE; Fardo DW Acta Neuropathol; 2019 Aug; 138(2):187-199. PubMed ID: 30949760 [TBL] [Abstract][Full Text] [Related]